Loading...
SITCSection 8
U.S. imports of ozone, oxygen, aerosol & other therapeutic respiration apparatus (SITC 87233) totaled $321.1M in July 2026, traded with 50 countries.
Importers of Ozone, Oxygen, Aerosol & Other Therapeutic Respiration Apparatus paid $5.3M in duties in July 2026 — an effective duty rate of 10% on $52.4M in dutiable value, based on actual customs collections rather than the published tariff schedule. Ozone, Oxygen, Aerosol & Other Therapeutic Respiration Apparatus imports of $321.1M in July 2026 ran 11% below the year-to-date monthly average of $362.5M.
Basic heading 28 of 419 in section 8
Basic heading 87233 · $321.1M of $44.8B
Oxygen concentrators, aerosol therapy nebulizers, artificial respiration ventilators, and ozone therapy units share this heading, making it one of the more heterogeneous groupings in the medical-device trade schedule. Ventilators and high-acuity respiratory devices are typically subject to FDA 510(k) clearance or premarket approval requirements, and importers must verify that foreign manufacturers hold the appropriate FDA establishment registration. Aerosol drug-delivery devices may additionally require coordination with FDA's Center for Drug Evaluation and Research if the device is co-packaged with a drug product. Supply-chain disruptions for critical respiratory equipment — highlighted during recent public-health emergencies — have made origin diversification and safety-stock planning a priority for hospital procurement teams.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
10.8K shipments/mo
Yes. Ventilators and oxygen concentrators are Class II or Class III medical devices regulated by FDA's Center for Devices and Radiological Health. Imported units must originate from FDA-registered foreign establishments, and FDA may detain shipments for examination. Emergency Use Authorizations issued during public-health emergencies can temporarily modify these requirements, but importers should confirm current status with FDA or a licensed customs broker before each shipment.
Combination products — a device co-packaged or co-marketed with a drug — are assigned a primary mode of action by FDA's Office of Combination Products, which then designates the lead review center. The customs entry should reflect the correct HTS classification for the device component, but the importer must also satisfy any drug-import requirements for the pharmaceutical portion. Early engagement with FDA and a licensed customs broker is strongly recommended for combination-product shipments.
Supplier Network
Get discovered by U.S. importers searching for HS 87233 — Ozone, Oxygen, Aerosol & Other Therapeutic Respiration Apparatus. Be the first supplier listed.
Imports · July 2026
origin
Singapore and China together supply 47% of it.
customs district
Census does not publish district detail for this classification system.
destination
Census does not publish state detail for this classification system.
entry
Census does not publish port detail for this classification system.
ImportsExports
Imports
$321.1MYoY · Pro
Exports
$99.8MYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.